Western Oncolytics is a privately held biotechnology company structured around development of a new generation of optimized, multi-mechanistic cancer immunotherapies. The firmâs oncolytic vaccinia virus immunotherapies are designed with proprietary, synergistic combinations of genetic modifications systemically to target and destroy cancer cells while enhancing patientsâ anti-tumor immune response. Western Oncolytics Ltd. has been working on WO-12, an immuno-oncolytic therapy that stimulates a directed immune attack against cancer while removing blocks to immune activity in tumor environments, as well as works in combination with other therapi
